EUCTR2007-005462-12-SE进行中（未招募）不适用
A prospective, randomized, masked and controlled trial of intravitreal ranibizumab (Lucentis®) combined with transpupillary thermotherapy (TTT) in patients with neovascular age-related macular degeneration (AMD)
St. Eriks Eye Hospital0 个研究点目标入组 100 人开始时间: 2007年10月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with neovascular AMD age 50 years or older who have a visual acuity of 0.1 (20/200) or better
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients aged < 50 years
- •BCVA < 0.1
- •Subfoveal fibrosis or atrophy
- •Previous treatment for neovascular AMD
- •CNV of other causes that AMD
- •Intraocular surgery within 3 months
- •Untreated glaucoma
- •Inflammation or infection in study eye
- •Retinal vascular disease of any origin
研究者
相似试验
进行中（未招募）
不适用
A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin®) for central retinal vein occlusion (CRVO).Central retinal vein occlusion (CRVO) is a sight-threatening ocular condition without efficient treatment.EUCTR2008-006265-93-SESt Eriks Eye Hospital60
进行中（未招募）
不适用
A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin) versus verteporfin photodynamic therapy (PDT) in patients with neovascular age-related macular degeneration.EUCTR2006-001200-36-SESt. Eriks Eye Hospital100
招募中
不适用
A prospective clinical trial for the treatment of keratoconjunctivitis caused by microsporidia.CTRI/2011/11/002132Hyderabad Eye Research Foundation72
进行中（未招募）
不适用
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures. - TIMELI 001nilateral, uncomplicated primary inguinal hernia repairClassification code 10022020EUCTR2005-002741-39-DKniversità di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggiore Policlinico, Padiglione328
进行中（未招募）
1 期
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures.EUCTR2005-002741-39-ESPr Giampiero CAMPANELLI - Ospedale Maggiore Policlinico, Padiglione Beretta Est328